ABIOMED INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Abiomed Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2022.
- Abiomed Inc Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was -$6.37M, a 201% decline year-over-year.
- Abiomed Inc annual Deferred Income Tax Expense (Benefit) for 2021 was $2.41M, a 91.8% decline from 2020.
- Abiomed Inc annual Deferred Income Tax Expense (Benefit) for 2020 was $29.4M, a 10.8% decline from 2019.
- Abiomed Inc annual Deferred Income Tax Expense (Benefit) for 2019 was $33M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)